94101 ⎘
Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring; Indoles; Hydrogenated indoles with substituted hydrocarbon radicals attached to carbon atoms of the hetero ring; Radicals substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals substituted additionally by nitrogen atoms, e.g. tryptophane
METHOD FOR PREPARING FMOC-TRP(BOC)-OH
#2AMINO ACID AND CARBOHYDRATE PSILOCIN DERIVATIVES
#3ARYL-IMINO TRYPTOPHAN DERIVATIVES
#4AMINE SEPARATION METHOD
#5ENGINEERED SYNTHASE FOR PRODUCTION OF TRYPTOPHAN DERIVATIVES AND INTRANSIGENT SUBSTRATES
#6METHODS FOR PREPARING L-6-HYDROXYTRYPTOPHAN (HTP) DERIVATIVE AND INTERMEDIATES THEREOF
#7FUSED BICYCLIC ALKYLENE LINKED IMIDODICARBONIMIDIC DIAMIDES, METHODS FOR SYNTHESIS, AND USES IN THERAPY
#8NOVEL AMINO ACID DERIVATIVES
#9SYNTHESIS OF (S)-6-HYDROXYTRYPTOPHAN AND DERIVATIVES THEREOF
#10OXER1 ANTAGONISTS AND USES THEREOF
#11KAT6 Inhibitors
#12LINKERS FOR ANTIBODY DRUG CONJUGATES
#13PROCESS FOR MANUFACTURING MACROCYCLIC PEPTIDES
#14SQUARAINE FLUOROPHORES
#15COMPOUNDS
#16PSMA-TARGETED NIR DYES AND THEIR USES
#17FUSED BICYCLIC ALKYLENE LINKED IMIDODICARBONIMIDIC DIAMIDES, METHODS FOR SYNTHESIS, AND USES IN THERAPY
#18AMIDE DERIVATIVES OF N-UREA SUBSTITUTED AMINO ACIDS AS FORMYL PEPTIDERECEPTOR LIKE-1 (FPRL-1) RECEPTOR MODULATORS
#19USP30 INHIBITORS AND USES THEREOF
#20LIPID NANOMATERIALS AND USES THEREOF
#21PRODRUGS OF 6-DIAZO-5-OXO-L-NORLEUCINE
#22METHOD FOR CRYSTALLIZATION OF AROMATIC AMINO ACIDS, ENABLING SUSTAINABLE CYCLE OF AMMONIA
#23SYNTHESIS OF N,N-DIMETHYLTRYPTAMINE-TYPE COMPOUNDS, METHODS, AND USES
#24MODULATORS OF SORTILIN ACTIVITY
#25Chemoselective Rapid Azo-Coupling Reaction for Bioconjugation
#26INHIBITORS OF SOLUTE CARRIER FAMILY 6A MEMBER 19 (SLC6A19) AND METHODS OF USE THEREOF
#27ENGINEERED SYNTHASE FOR PRODUCTION OF TRYPTOPHAN DERIVATIVES AND INTRANSIGENT SUBSTRATES
#28ESTER ANALOGS OF PSILOCIN, PROCESSES FOR THE PREPARATION THEREOF, AND METHODS OF USE
#29METHODS, COMPOUNDS, COMPOSITIONS AND VEHICLES FOR DELIVERING 3-AMINO-1-PROPANESULFONIC ACID
#30Linkers for antibody drug conjugates
#31Method for Concentrating Raw Material Solution, and System for Concentrating Raw Material Solution
#32THERAPEUTIC COMPOUNDS AND METHODS
#33Novel Glutamine Analogs
#34C4-carboxylic acid-substituted tryptamine derivatives and methods of using
#35C4-carboxylic acid-substituted tryptamine derivatives and methods of using
#36C-carbonothioate-substituted tryptamine derivatives and methods of using
#37Synthesis of N,N-dimethyltryptamine-type compounds, methods, and uses
#38a-CARBONYL ALKENYL ESTER PREPARATION METHOD THEREFOR AND APPLICATION THEREOF
#39CRYSTALLINE FORMS OF SOLVATES OF TRYPTOPHAN DERIVATIVES, COMPOSITIONS COMPRISING THEM AND USES THEREOF
#40METHOD FOR SYNTHESIS OF THIOETHER-CONTAINING PEPTIDES
#41Amino Acid Composition and Method for Catalytic Synthesis of Amino Acid by Means of Energy Radiation
#42Indoles, Indazoles, and Related Analogs for Inhibiting YAP/TAZ-TEAD
#43Compounds
#44Compositions and methods for treating and preventing neurodegenerative disorders
#45AMINO ACID-, PEPTIDE- AND POLYPEPTIDE-LIPIDS, ISOMERS, COMPOSITIONS, AND USES THEREOF
#46PANTETHENOYLCYSTEINE DERIVATIVES AND USES THEREOF
#47Glycosylated psilocybin derivatives and methods of using
#48PHYSICS-DRIVEN DISCOVERY OF NOVEL SMALL THERAPEUTIC COMPOUNDS FOR USE AS A BCL-2 INHIBITOR
#49DRG-MDM2-5 FOR USE AS A NOVEL MOUSE DOUBLE MINUTE 2 (MDM2) INHIBITOR
#50Glutamine antagonists and uses thereof
#51DITERPENOID COMPOUNDS THAT ACT ON PROTEIN KINASE C (PKC)
#52COMPOUNDS FOR THE TREATMENT OF HUMAN IMMUNODEFICIENCY VIRUS
#53COMPOUNDS FOR THE TREATMENT OF PARAMYXOVIRUS VIRAL INFECTIONS
#54TUCARESOL DERIVATIVES AND USES THEREOF
#55SULFUR AND AMIDE TROPOLONE INHIBITORS OF NUCLEOTIDYL TRANSFERASES AND USES THEREFOR
#56Myeloperoxidase Imaging Agents
#57CALPAIN MODULATORS AND THERAPEUTIC USES THEREOF
#58SMALL-MOLECULAR ADJUVANTS AND IMPLEMENTATIONS THEREOF
#59SYNTHETIC LIPID-LIKE MATERIALS FOR BRAIN DELIVERY
#60USP30 inhibitors and uses thereof
#61PIGMENTED AND FLUORESCENT COMPOUNDS DERIVED FROM THE ADDITION OF A PRIMARY OR SECONDARY AMINE TO AN ALDEHYDE
#62Method for photocleavage of amide bonds
#63Compounds
#64Engineered synthase for production of tryptophan derivatives and intransigent substrates
#65Fused bicyclic alkylene linked imidodicarbonimidic diamides, methods for synthesis, and uses in therapy
#66NOVEL COMPOUND HAVING ANTICANCER ACTIVITY, AND METHOD FOR PRODUCING SAME
#67AMIDE DERIVATIVES OF N-UREA SUBSTITUTED AMINO ACIDS AS FORMYL PEPTIDE RECEPTOR LIKE-1 (FPRL-1) RECEPTOR MODULATORS
#68Method of preparing a DON prodrug from L-pyroglutamic acid
#69NOVEL COMPOUND AND METHOD FOR PREVENTING OR TREATING OF RESPIRATORY DISEASES COMPRISING THE SAME AS AN ACTIVE INGREDIENT
#70FLUORINATION METHOD
#71Ketoamide compound and preparation method, pharmaceutical composition, and use thereof
#72HCV protease inhibitors
#73Enhancer of fertilization function of sperm
#74PSMA-TARGETED NIR DYES AND THEIR USES
#75ETHYLENEDIAMINE COMPOUND AND USE THEREOF
#76DUAL FUNCTION MOLECULES FOR HISTONE DEACETYLASE INHIBITION AND ATAXIA TELANGIECTASIA MUTATED ACTIVATION AND METHODS OF USE THEREOF
#77Estrogen receptor antagonist
#78Synthesis of (S)-6-Hydroxytryptophan and Derivatives Thereof
#79Synthesis of N,N-dimethyltryptamine-type compounds, methods, and uses
#80METHODS, COMPOUNDS, COMPOSITIONS AND VEHICLES FOR DELIVERING 3-AMINO-1-PROPANESULFONIC ACID
#81Synthetic lipid-like materials for brain delivery
#82AMINO ACID SALTS OF NICOTINIC ACID MONONUCLEOTIDE AND NICOTINAMIDE MONONUCLOETIDE AS ANTI-AGEING AGENTS
#83Prodrugs of glutamine analogs
#84Heterocyclic P2Yreceptor antagonists
#85PSMA-targeted NIR dyes and their uses
#86Amide compounds and use thereof
#87Compositions and methods for treating and preventing neurodegenerative disorders
#88Amino acid-, peptide- and polypeptide-lipids, isomers, compositions, and uses thereof
#89Haloallylamine indole and azaindole derivative inhibitors of lysyl oxidases and uses thereof
#90DUAL FUNCTION MOLECULES FOR HISTONE DEACETYLASE INHIBITION AND ATAXIA TELANGIECTASIA MUTATED ACTIVATION AND METHODS OF USE THEREOF
#91Mild and efficient preparation method for α-acyloxyenamide compounds and use thereof in synthesis of amide and polypeptide
#92TRYPTOPHAN DERIVATIVES AS SWEETENERS
#93Salts and prodrugs of 1-methyl-d-tryptophan
#94Methods, compounds, compositions and vehicles for delivering 3-amino-1-propanesulfonic acid
#95COMPOUND HAVING ENHANCING ACTIVITY FOR GLUCAGON-LIKE PEPTIDE-1 RECEPTOR ACTIONS
#96Calpain modulators and therapeutic uses thereof
#97Structure and synthesis of highly fluorinated amino acid derivatives
#98Linkers for antibody drug conjugates
#99Methods, compounds, compositions and vehicles for delivering 3-amino-1-propanesulfonic acid
#100Fused bicyclic alkylene linked imidodicarbonimidic diamides, methods for synthesis, and uses in therapy
#101Amide derivatives of N-urea substituted amino acids as formyl peptide receptor like-1 (FPRL-1) receptor modulators
#102Prodrugs of glutamine analogs
#103Prodrugs of glutamine analogs
#104Myeloperoxidase imaging agents
#105Inhibitors of tryptophan 2,3-dioxygenase
#106ARYL SUBSTITUTED INDOLES AND THE USE THEREOF
#107Antimicrobial compounds
#108DNA primase and gyrase inhibitors
#109SALTS AND PRODRUGS OF 1-METHYL-D-TRYPTOPHAN
#110Rational drug design targeting resistant gram-negative bacterial infections to polymyxin-class antibiotics
#111Antagonists of the glucagon receptor
#112Mild and efficient preparation method for α-acyloxyenamide compounds and use thereof in synthesis of amide and polypeptide
#113Bis-amino acid based compound and use thereof
#114PTEN binding compounds, formulations, and uses thereof
#115PSMA-targeted NIR dyes and their uses
#116Modulators of ATP-binding cassette transporters
#117INDOLE AND INDAZOLE CYANOCINNAMATE COMPOUNDS AND THERAPEUTIC USES THEREOF
#118Indole and azaindole haloallylamine derivative inhibitors of lysyl oxidases and uses thereof
#119TERTIARY AMIDES AND METHOD OF USE
#1205-methoxytryptophan and its derivatives and uses thereof
#121Alpha-Ketoamide Inhibitors Of Cysteine Proteases
#122Amino acid-, peptide- and polypeptide-lipids, isomers, compositions, and uses thereof
#123Haloallylamine indole and azaindole derivative inhibitors of lysyl oxidases and uses thereof
#124COMPOUND HAVING ENHANCING ACTIVITY FOR GLUCAGON-LIKE PEPTIDE-1 RECEPTOR ACTIONS
#125Chemoselective rapid azo-coupling reaction for bioconjugation
#126Erythropoietin expression promoter
#127ANTIBIOTIC AMINO ACID MIMETICS
#128Z-SELECTIVE OLEFIN METATHESIS OF PEPTIDES
#129CCK2R-drug conjugates
#130Amide derivatives of N-urea substituted amino acids as formyl peptide receptor like-1 (FPRL-1) receptor modulators
#131Prodrugs of glutamine analogs
#132METHOD AND COMPOSITION FOR RETAINING NUTRIENTS IN SOIL AT PLANTING SITES
#133METHOD FOR ISOLATION OF ALKALOIDS AND AMINO ACIDS, AND COMPOSITIONS CONTAINING ISOLATED ALKALOIDS AND AMINO ACIDS
#134Salts and prodrugs of 1-methyl-D-tryptophan
#135PHARMACEUTICAL COMPOSITION CONTAINING A TRYPTOPHAN DERIVATIVE
#136Curcumin conjugates and methods of use thereof
#137PSMA-targeted NIR dyes and their uses
#138Engineered synthase for production of tryptophan derivatives and intransigent substrates
#139Dual function molecules for histone deacetylase inhibition and ataxia telangiectasia mutated activation and methods of use thereof
#140Dual function molecules for histone deacetylase inhibition and ataxia telangiectasia mutated activation and methods of use thereof
#141Aryl substituted indoles and the use thereof
#1425-METHOXYTRYPTOPHAN AND ITS DERIVATIVES AND USES THEREOF
#143Use of ester derivative of tryptophan as deodorant and/or perfume agent
#144Heterocyclic derivatives as RORgamma modulators
#145Ethynylbenzene derivatives
#146PSMA—targeted NIR dyes and their uses
#147Broad-spectrum non-covalent coronavirus protease inhibitors
#148Compounds for the treatment of paramyxovirus viral infections
#149PSMA-targeted NIR dyes and their uses
#150FORMULATION AND METHOD TO INDUCE A DEEP STATE OF RELAXATION
#151Antagonists of the glucagon receptor
#152ABIETANE-TYPE DITERPENOIDS
#153Molecular probes for multimodality imaging and tracking of stem cells
#154Low-molecular-compound for improving production, maintenance and proliferation of pluripotent stem cells, composition comprising the same, and culture method
#155Amide derivatives of N-urea substituted amino acids as formyl peptide receptor like-1 (FPRL-1) receptor modulators
#156Methods, compounds, compositions and vehicles for delivering 3-amino-1-propanesulfonic acid
#157PSMA-targeted NIR dyes and their uses
#158PSMA-targeted NIR dyes and their uses
#159N-alkoxyamide conjugates as imaging agents
#160Salts and prodrugs of 1-methyl-D-tryptophan
#161Pharmaceutical compound
#162NOVEL INDOLE DERIVATIVE COMPOUND AND PHARMACEUTICAL COMPOSITION COMPRISING THE SAME
#163METHOD FOR ISOLATION OF ALKALOIDS AND AMINO ACIDS, AND COMPOSITIONS CONTAINING ISOLATED ALKALOIDS AND AMINO ACIDS
#164Method for purifying aromatic amino acids
#165ARYL SUBSTITUTED INDOLES AND THE USE THEREOF
#166Dual function molecules for histone deacetylase inhibition and ataxia telangiectasia mutated activation and methods of use thereof
#167Glucagon receptor antagonist compounds, compositions containing such compounds and methods of use
#168Heterocyclic coupling catalysts and methods related thereto
#169Amide derivatives of N-urea substituted amino acids as formyl peptide receptor like-1 (FPRL-1) receptor modulators
#170Organic compounds
#171Indole derivatives and process for their preparation
#172Biomarker and Method for Determining an Oxidative Stress Level
#173N-alkoxyamide conjugates as imaging agents
#174CATALYST AND RELATED METHODS
#175Process for obtaining ionic amino acid esters
#176Fluorescent compounds and uses thereof
#177Antagonists of the glucagon receptor
#178Erythropoietin expression promoter
#179Beta-alanine derivatives, pharmaceutically acceptable salts thereof, and pharmaceutical composition comprising same as active ingredient
#180Axially chiral N-(2-acylaryl)-2-[5,7-dihydro-6h-dibenzo[c,e]azepin-6-yl] acetamide compound and chirality interconversion method of a-amino acid using the same
#181FPR1 antagonist derivatives and use thereof
#182Compounds for the treatment of paramoxyvirus viral infections
#183Aldehyde capture ligation technology for synthesis of amide bonds
#184PHARMACEUTICALLY ACCEPTABLE SALTS OF THYMODEPRESSIN AND PROCESSES FOR THEIR MANUFACTURE
#185Purification apparatus including continuous reactors and purification method using continuous reactors
#186Purification System Comprising Continuous Reactor and Purification Method Using Continuous Reactor
#187Low-molecular-compound for improving production, maintenance and proliferation of pluripotent stem cells, composition comprising the same, and culture method
#188Benzenesulfonamide compounds, method for synthesizing same, and use thereof in medicine as well as in cosmetics
#189Amide derivatives of N-urea substituted amino acids as formyl peptide receptor like-1 (FPRL-1) receptor modulators
#190Configurational chirality based separation
#191Molecular probes for multimodality imaging and tracking of stem cells
#192Treatment of drug-resistant cancer with 2-aryl-2-(3-indolyl) acetohydroxamates
#193FPR1 ANTAGONIST DERIVATIVES AND USE THEREOF
#194N-alkoxyamide conjugates as imaging agents
#195Guanidinobenzoic acid compound
#196Substituted 4-aminocyclohexane derivatives
#197Modulators of ATP-binding cassette transporters
#198PRODRUGS OF D-ISOGLUTAMYL-[D/L]-TRYPTOPHAN
#199PHOTOACID COMPOUNDS, AND RELATED COMPOSITIONS, METHODS AND SYSTEMS
#200Caged compound delivery and related compositions, methods and systems
#201Amide derivative and whitening agent
#202Use of derivatives of indoles for the treatment of cancer
#203Use of photocleavable compounds
#204Bis-indolic derivatives, their uses in particular as antibacterials
#205Methods, compounds, compositions and vehicles for delivering 3-amino-1-propanesulfonic acid
#206Naphthoquinone derivatives useful for prevention of amyloid deposits and treatment of diseases involving amyloidogenesis
#207N-substituted isopropyldimethyl azulene sulfonamide derivatives, and preparation method and use thereof
#208MODULATORS OF ATP-BINDING CASSETTE TRANSPORTERS
#209MODULATORS OF ATP-BINDING CASSETTE TRANSPORTERS
#210Antagonists of the glucagon receptor
#211Benzenesulfonamide compounds, method for synthesizing same, and use thereof in medicine as well as in cosmetics
#212Bcl-2-selective apoptosis-inducing agents for the treatment of cancer and immune diseases
#213Amide derivatives of N-urea substituted amino acids as formyl peptide receptor like-1 (FPRL-1) receptor modulators
#214Indole derivative or pharmaceutically acceptable salt thereof, preparation method thereof, and pharmaceutical composition for preventing or treating metabolic diseases containing same as active ingredient
#215Organogold complexes and methods for making the same
#216POSITIVE PHOTOSENSITIVE RESIN COMPOSITION, METHOD FOR FORMING CURED FILM, CURED FILM, ORGANIC EL DISPLAY DEVICE AND LIQUID CRYSTAL DISPLAY DEVICE
#217p53-Mdm2 antagonists
#218Aryl urea derivatives as N-formyl peptide receptor like-1 (FPRL-1) receptor modulators
#219Use of glutaric acid derivatives or the pharmaceutically acceptable salts thereof as anti-arrhythmic agents
#220N-alkoxyamide conjugates as imaging agents
#221Inhibitors of p75 receptor and their uses
#222BCL-2 selective apoptosis-inducing agents for the treatment of cancer and immune diseases
#223Aryl substituted indoles and their use as blockers of sodium channels
#224Indole derivatives and process for their preparation
#225Chemosensory Receptor Ligand-Based Therapies
#226Peptidomimetic compounds as immunomodulators
#227Ethynylbenzene derivatives
#228Formulation and method to induce a deep state of relaxation
#229Substituted 4-aminocyclohexane derivatives
#230PHARMACEUTICAL COMPOSITION CONTAINING A TRYPTOPHAN DERIVATIVE
#231SALTY TASTE ENHANCER
#232METHOD FOR PRODUCING CRYSTALS OF MUTIVALENT METAL SALT OF (2R, 4R) MONATIN
#233Amino acid-, peptide-and polypeptide-lipids, isomers, compositions, and uses thereof
#234Use of derivatives of indoles for the treatment of cancer
#235Compositions and methods for treating cancer
#236Aryl urea derivatives as N-formyl peptide receptors like-1 (FPRL-1) receptor modulators
#237Amide derivatives of N-urea substituted amino acids as formyl peptide receptor like-1 (FPRL-1) receptor modulators
#238Method for Separating off Tryptophan
#239Pharmaceutically acceptable salts of thymodepressin and processes for their manufacture
#240Compounds for immunoproteasome inhibition
#241Biomarker and Method for Determining an Oxidative Stress Level
#242Crystalline forms of the mono-sodium salt of D-isoglutamyl-D-tryptophan
#243Crystalline forms of the mono-sodium salt of D-isoglutamyl-D-tryptophan
#244Modulators of ATP-binding cassette transporters
#245Therapeutic peptides
#246Modulators of ATP-binding cassette transporters
#247CRYSTAL OF MULTIVALENT METAL SALT OF MONATIN
#248Crystalline forms of the mono-sodium salt of D-isoglutamyl-D-tryptophan
#249Benzenesulfonamide compounds, method for synthesizing same, and use thereof in medicine as well as in cosmetics
#250POLYMER AND METHODS OF PREPARING AND USING A POLYMER
#251Heterocyclic CETP inhibitors
#252Method for producing intermediates for the production of macrocycles that are inhibitors of the proteasomic degradation of p27, such as argyrin and derivatives thereof
#253CRYSTALS OF NON-NATURAL-TYPE STEREOISOMER SALT OF MONATIN AND USE THEREOF
#254HYDRATE CRYSTALS
#255Antagonists of the glucagon receptor
#256Substituted 4-aminocyclohexane derivatives
#257Facile amide formation via S-nitroso thioacid intermediates
#258INDOLEAMINE 2,3-DIOXYGENASE PATHWAYS IN THE GENERATION OF REGULATORY T CELLS
#259Process for preparing heteroaromatic ring compound having N-Rf group
#260Compositions and methods for the treatment of disease associated with TRP-P8 expression
#261NOVEL AMIDE DERIVATIVE AND WHITENING AGENT
#262Positive photosensitive resin composition, method for forming cured film, cured film, organic el display device and liquid crystal display device
#263PROCESSES OF PRODUCING GLUTAMIC ACID COMPOUNDS AND PRODUCTION INTERMEDIATES THEREFORE AND NOVEL INTERMEDIATE FOR THE PROCESSES
#264NOVEL COMPOUNDS FOR MEDICAL USE AS PEPTIDASE EFFECTORS
#265Method for obtaining optically pure amino acids
#266Use of Glutaric Acid Derivatives or the Pharmaceutically Acceptable Salts Thereof as Anti-Arrhythmic Agents
#267Naphthoquinone derivatives useful for prevention of amyloid deposits and treatment of diseases involving amyloidogenesis
#268HYDRATE CRYSTALS
#269Treatment or Prevention of Hepatitis C with Immunomodulator Compounds
#270CRYSTALS OF NON-NATURAL-TYPE STEREOISOMER SALT OF MONATIN AND USE THEREOF
#271Anti-Heparin Compounds
#272Amino acid derivative
#273Dye for dye-sensitized solar cell, semiconductor electrode, and dye-sensitized solar cell
#274Alpha-amino-N-substituted amides, pharmaceutical composition containing them and uses thereof
#275Crystals of non-natural-type stereoisomer salt of monatin and use thereof
#276Cyclic hydrocarbon compounds for the treatment of diseases
#277Nitric oxide amino acid ester compound, composition for increasing nitric oxide levels and method of use
#278BCL-2-selective apoptosis-inducing agents for the treatment of cancer and immune diseases
#279N-acyl amino acid derivatives, a method for the preparation thereof, a pharmaceutical composition and use thereof as anti-allergic, anti-inflammatory and hypolipidemic agents
#280Heterocyclic CETP inhibitors
#281Process for preparing heteroaromatic ring compound having N-Rf group
#282DECHALCOGENATIVE METHODS FOR THE PREPARATION OF ALLYLIC SULFIDES
#283Biomarker and Method for Determining an Oxidative Stress Level
#284Modified malonate derivatives
#285Polynucleotides encoding soluble, stable forms of human double minute 2 polypeptides
#286Methods and compositions for treating amyloid-related diseases
#287PROCESSES OF PRODUCING GLUTAMIC ACID COMPOUNDS AND PRODUCTION INTERMEDIATES THEREFORE AND NOVEL INTERMEDIATE FOR THE PROCESSES
#288Nitric oxide amino acid ester compound, compositions for increasing nitric oxide levels and method of use
#289Pharmaceutically acceptable salts of thymodepressin and processes for their manufacture
#290Stable isotope-labeled aromatic amino acids, method for incorporating the same in target protein and method for NMR-structural analysis of proteins
#291Methods for the use of inhibitors of cytosolic phospholipase A2
#292Urea and sulfamide derivatives as inhibitors of TAFIa
#293Crystalline forms of the mono-sodium salt of D-isoglutamyl-D-tryptophan
#294Cyanine compound and optical filter and optical recording material containing same
#295Monatin hydrate crystals
#296AGONISTS AND ANTAGONISTS OF THE SOMATOSTATIN RECEPTOR
#297Modulators of ATP-binding cassette transporters
#298ENDOTHELIN RECEPTOR ANTAGONIST DERIVATIVES
#299Processes of producing glutamic acid compounds and production intermediates therefore and novel intermediate for the processes
#300N-alkoxyamide conjugates as imaging agents